I wonder whether looking at patients cytokines in studies would make more sense and be more consistant if the patients were divided into groups depending on whether they get any fevers/cold/flu or not?
I doubt anyone has looked but it would surely be pretty simple and cheap to add to such a study.
@
Jonathan Edwards - what do you think?
Cytokines measurements over many days is what Dr. Montoya has been doing and probably continues to do @ Stanford.
Also Dr. Kogelnik with Dr. Ron Davis and Dr. Mark Davis (both @ Stanford and both on the Science Board of OMI) are working on such markers, but their approach is very different from anything and anybody's previous ways of looking at the immune system.
They will find the answers because they are asking different questions and most importantly they have a systemic approach.
I think that they will do what @
Jonathan Edwards has done in the RA treatment field back in the early 90's, in the ME field specifically, and more generally in immunology.